Difference in Length of Stay and Treatment Outcome of Pulmonary Tuberculosis Inpatients between Health Insurance Types

의료보장유형에 따른 폐결핵 입원환자의 재원기간과 치료결과 차이분석

  • Kim, Sang Mi (Dept. of Medical Information, Korea Polytechnics) ;
  • Lee, Hyun Sook (Dept. of Health Administration, Kongju National University) ;
  • Hwang, Seul ki (Dept. of Health Administration, Suwon Women's University)
  • 김상미 (한국폴리텍대학 의료정보과) ;
  • 이현숙 (국립공주대학교 보건행정학과) ;
  • 황슬기 (수원여자대학교 보건행정학과)
  • Received : 2016.09.19
  • Accepted : 2016.11.30
  • Published : 2016.12.30

Abstract

The purpose of this study is to identify patient and hospital characteristics with pulmonary tuberculosis and to analyze factors which were influencing length of stay and treatment. The Korean National Hospital Discharge In-depth Injury Survey database from 2006 to 2012 was used for analysis. Study subjects were 4,704 patients and analyzed by using frequency, chi-square and logistic regression through using STATA 12.0. To avoid selection bias, we used propensity score matching. Analysis results show that the length of stay and treatment of pulmonary tuberculosis was different between insurance types. Patients characteristic(female, comorbidity, admission by outpatient department, medical insurance type) and hospital characteristic(500-999 beds, over 1000 beds) significantly influence length of stay. Admission by outpatient department and over 1000 beds are significantly influence treatment. Based on these findings, it is necessary to clarify between length of stay and treatment outcome by medical aids beneficiaries and audit hospitals follow discharge guidelines in pulmonary tuberculosis patients.

Keywords

References

  1. Korean Association of Health Promotion. Tuberculosis. Korean Ass Heal Prom 2006;30(5):30-31.
  2. Dheda K, Barry 3rd C.E, Maartens G. Tuberculosis. The Lancet 387 2016:1211-1226. https://doi.org/10.1016/S0140-6736(15)00151-8
  3. WHO. Global tuberculosis report 2015.
  4. Oh SH. TB clinic-Directly Observed Treatment (DOT) Pilot Project of Tuberculosis Patient. World Health 2012;59(3):8-12.
  5. Park JI. "Super Tuberculosis' increased foreign patients, Scary than AIDS. Gangwon J. [cited 2016 Aug 25]. Available from http://blog.naver.com/cnatkdnl1/220477976762 (September 19, 2016)
  6. WHO. Tuberculosis (now more than ever). [cited 2016 Aug 25]. Available from http://www.who.int/mediacentre/factsheets/fs104/en/index.html (April, 21, 2016)
  7. Korean National Tuberculosis Association. Tuberculosis Management. 2001
  8. Kim DS. Only 500 Inpatients by Admission Order... severe tuberculosis over 4,000 people. ChosunIlbo. [cited 2016 Aug 25]. Available from http://news.chosun.com/site/data/html_dir/2012/07/23/2012072302636.html (April, 21, 2016)
  9. Kang HY. Analysis of tuberculosis burden in OECD member countries, 2011- Global Tuberculosis Control WHO Report 2012. Korea Centers for Disease Control and Prevention. 2013.
  10. Ministry of Health and Welfare. Statistical Yearbook of Medical Aid. National Health Insurance Service. 2013.
  11. Lee S, Lim JY. The Effects of Introduction of Co-payment System on the Medical Aid Beneficiaries' Health Care Usage in Korea. The Korean Journal of Health Economics and Policy 2013;19(3):23-49.
  12. Lee HJ. Healthcare utilization and out-ofpocket spending of Medical Aids recipients in South Korea: a propensity score matching with National Health Insurance participants. The Korean Journal of Health Economics and Policy 2016;22(2):29-49.
  13. Park YH. Utilization Patterns of National Health Insurance and Medical Aid Inpatients in Tertiary Hospitals. The Korean Journal of Health Service Management 2012;6(4):83-98. https://doi.org/10.12811/kshsm.2012.6.4.083
  14. Seo EW, Lee KS. Difference in Healthcare Utilization for Percutaneous Transluminal Coronary Angioplasty Inpatients by Insurance Types: Propensity Score Matching Analysis. Health Policy and Management 2015;25(1):3-10. https://doi.org/10.4332/KJHPA.2015.25.1.3
  15. Lee YJ. Differences of Cancer Patient's Health Care Utilizations between Medical Aid Program and National Health Insurance in the Elderly. International JOURNAL OF CONTENTS 2011; 11(5):270-279.
  16. Youn K. The Effects of Patient and Hospital characteristics on Hospital Care Outcome of the Patients with Tuberculosis. J Korean Society of Hospital Management 2014;19(2):44-54.
  17. Lee HS, Hwang SK, Kim SM. Factors Influencing Treatment Result in Inpatients with Tuberculosis. International JOURNAL OF CONTENTS 2016;16(10): 10-17.
  18. Park W, Na Y, Choi J. Spatial Distribution and Management of Tuberculosis Patients in South Korea. The Geographical Journal of Korea 2015;49(3):371-381.
  19. Korea Centers for Disease Control and Prevention. 8th National Hospital Discharge Injury Data Guide. 2012.
  20. Jindani A, Dore CJ, Mitchison DA. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 2003;167:1348-1354. https://doi.org/10.1164/rccm.200210-1125OC
  21. Long R. Canadian Tuberculosis Standards, 6th edition. Ottawa: Canadian Lung Association and Public Health Agency of Canada 2007.
  22. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36(1):8-27. https://doi.org/10.1097/00005650-199801000-00004
  23. Kim KH. Comorbidity Adjustment in Health Insurance Claim Database. Health Policy and Management 2016;26(1):71-78. https://doi.org/10.4332/KJHPA.2016.26.1.71
  24. Austin PC. A comparison of 12 algorithms for matching on the propensity score Statist. Med 2014;33:1057-1069 (wileyonlinelibrary.com) DOI:10.1002/sim.6004
  25. Nam MH, Lim JH. Analysis on the situation of inpatients with pressure ulcer by patient safety indicators. J Society of Digital Policy & Management 2012;10(3):197-205.
  26. Kim SR. (A) Study on the comparison of inpatients healthcare utilization between the Medicaid recipients and the insured [dissertation]. Seoul: Yonsei University; 2000.
  27. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/ Deyo methods of comorbidity measurement in administrative data. Med Care 2004;42(4):355-360. https://doi.org/10.1097/01.mlr.0000118861.56848.ee
  28. Ministry of Health and Welfare, Korea Centers for Disease Control & Prevention, National Tuberculosis Management Guideline. 2015.
  29. Shin SR, Kim Ch, Kim SE, Park YB, Lee JY, Mo EK, Kim CH et al. Predictors on In-hospital Mortality Following In-hospital Diagnosis of Tuberculosis. Tuberculosis and Respiratory Diseases 2006;61(3):233-237. https://doi.org/10.4046/trd.2006.61.3.233
  30. Stuart EA. Estimating causal effects using school-level data sets. Educational Researcher 2007;36:187-198. https://doi.org/10.3102/0013189X07303396
  31. Rosenbaum PR, Rubin DB, Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1983a; 79(387):516-524. https://doi.org/10.1080/01621459.1984.10478078
  32. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127(8_Pt 2):757-763. https://doi.org/10.7326/0003-4819-127-8_Part_2-199710151-00064
  33. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983b;70(1):41-55. https://doi.org/10.1093/biomet/70.1.41
  34. Jang YJ, Ahn JH, Jung SY, Lee JY, Sin JY. Methods for the control of measured confounders in outcomes research. National Evidence-based Healthcare Collaborating Agency 2013.
  35. Lee KO, A Study on Nonresponse Adjustment by Using Propensity Scores. Asian journal for public opinion research 2009;10(1):169-186.
  36. Snider GL. Tuberculosis then and now: a personal perspective on the last 50 years. Ann Intern Med 1997;126:237-243. https://doi.org/10.7326/0003-4819-126-3-199702010-00011
  37. Holmquist L, Russo a, Elixhauser A. Tuberculosis stays in U.S. Hospitals, 2006. National Institutes of Health, 2008.
  38. Taheri PA, Butz DA, Greenfield LJ. Length of stay has minimal impact on the cost of hospital admission. J Am Coll Surg 2000;191(2):123-130. https://doi.org/10.1016/S1072-7515(00)00352-5